Arthur He
Stock Analyst at HC Wainwright & Co.
(5)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ADAG Adagene | Maintains: Buy | 8 7 | 2.31 | 203.03% | 11 | Aug 15, 2025 | |
LVTX LAVA Therapeutics | Maintains: Neutral | 2 2 | 1.55 | -20% | 11 | Aug 5, 2025 | |
AUPH Aurinia Pharmaceutic... | Assumes: Buy | 17 | 12.43 | 36.77% | 1 | Jul 30, 2025 | |
ADAP Adaptimmune Therapeu... | Downgrades: Neutral | n/a | n/a | n/a | 7 | Jul 29, 2025 | |
NKTR Nektar Therapeutics | Maintains: Strong Buy | 7 120 | 40.48 | 196.44% | 4 | Jun 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 20 20 | 5.38 | 271.75% | 10 | Jun 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 75 85 | 24.45 | 247.65% | 2 | Jun 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 8 | May 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 8 | Mar 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 7 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 20 9 | 9.5 | -5.26% | 17 | Nov 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 39 | 40 | -2.5% | 4 | May 28, 2024 |